These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7160541)

  • 1. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
    Pérez Maceda B; Linde S; Sonne O; Gliemann J
    Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
    Zhou W; Li S; Deng S
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S; Sonne O; Hansen B; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
    Linde S; Hansen B
    Int J Pept Protein Res; 1980 May; 15(5):495-502. PubMed ID: 7002822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
    Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
    J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
    Zórad S; Svábová E; Klimes I; Macho L
    Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.
    Diaz JL; Wilkin TJ
    Clin Chem; 1988 Feb; 34(2):356-9. PubMed ID: 2449302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated degradation of insulin in isolated rat adipocytes. Formation of a degradation product slightly smaller than insulin.
    Sonne O
    Biochim Biophys Acta; 1987 Jan; 927(1):106-11. PubMed ID: 3539208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preparation and characterization of mono-iodinated photoreactive analogs of insulin.
    Heidenreich KA; Yip CC; Frank BH; Olefsky JM
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1138-45. PubMed ID: 3884003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization].
    Besch W; Woltanski KP; Knospe S; Ziegler M; Keilacker H
    Acta Biol Med Ger; 1980; 39(4):495-502. PubMed ID: 7004036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogeneous mono-(125)i-insulins. Preparation and characterization of mono-(125)i-(tyr a14)-and mono-(125)i-(tyr a19)-insulin.
    Jørgensen KH; Larsen UD
    Diabetologia; 1980; 19(6):546-54. PubMed ID: 7007134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of monoiodoinsulin.
    Linde S; Hansen B
    Int J Pept Protein Res; 1974; 6(3):157-63. PubMed ID: 4415172
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing rat brain binds monoiodinated insulin isomers similarly to other extrahepatic target tissues.
    Kappy MS; Clarke DW; Raizada MK; Boyd FT; Frank BH
    Brain Res; 1985 Dec; 360(1-2):195-202. PubMed ID: 3907754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.
    Clot JP; Janicot M; Fouque F; Desbuquois B; Haumont PY; Lederer F
    Mol Cell Endocrinol; 1990 Sep; 72(3):175-85. PubMed ID: 2289630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
    Misbin RI; Almira EC
    Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.